Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial.


Journal

Public health genomics
ISSN: 1662-8063
Titre abrégé: Public Health Genomics
Pays: Switzerland
ID NLM: 101474167

Informations de publication

Date de publication:
2024
Historique:
received: 11 03 2024
accepted: 18 07 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: ppublish

Résumé

When a pathogenic BRCA1 or BRCA2 mutation is identified in a family, cascade genetic testing of family members is recommended since the results may inform screening or treatment decisions in men and women. However, rates of cascade testing are low, and men are considerably less likely than women to pursue cascade testing. To facilitate cascade testing in men, we designed a Web-based genetic education tool that addressed barriers to cascade testing, was individually tailored, delivered proactively, and could be used in lieu of pretest genetic counseling to streamline the cascade testing process. We randomized 63 untested men from hereditary cancer families to Web-based genetic education (WGE) versus enhanced usual care (EUC). WGE participants were provided access to a genetic education website after which they could accept or decline genetic testing or opt for pretest genetic counseling. EUC participants received an informational brochure and a letter informing them of their eligibility for genetic testing and recommending they schedule genetic counseling. The primary outcome was the uptake of genetic testing. Men in the WGE group were more likely to complete genetic counseling and/or genetic testing (43% vs. 12.1%; χ2 [n = 63, df = 1] = 7.77, p = 0.005). WGE participants were also more likely to complete genetic testing compared to men in the EUC group (30% vs. 9.1%; χ2 [n = 63, df = 1] = 4.46, p = 0.03). This preliminary trial suggests that a streamlined approach to genetic testing using proactively delivered genetic education may reduce barriers to cascade testing for at-risk men, leading to increased uptake. These results should be interpreted cautiously given the select sample and high rate of non-response.

Identifiants

pubmed: 39173603
pii: 000540466
doi: 10.1159/000540466
doi:

Substances chimiques

BRCA2 Protein 0
BRCA1 Protein 0
BRCA2 protein, human 0
BRCA1 protein, human 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-109

Informations de copyright

© 2024 The Author(s). Published by S. Karger AG, Basel.

Auteurs

Christopher Grisham (C)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Beth N Peshkin (BN)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Lia Sorgen (L)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Claudine Isaacs (C)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Mary Kathleen Ladd (MK)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Aryana Jacobs (A)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Savannah Binion (S)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Mara Tynan (M)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Emily Kuchinsky (E)

Medstar Franklin Square Hospital, Baltimore, Maryland, USA.

Susan Friedman (S)

FORCE: Facing Our Risk of Cancer Empowered, Tampa, Florida, USA.

Kathryn L Taylor (KL)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Kristi Graves (K)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Suzanne O'Neill (S)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

David Kim (D)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Marc D Schwartz (MD)

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH